在线免费成人,天堂成人在线,最新日本中文字幕在线观看,国产区日韩,国内精品乱码卡一卡2卡麻豆,极品国产在线观看,婷婷在线免费

Nuclear Medicine And Molecular Imaging
收藏雜志
  • 數(shù)據(jù)庫收錄SCIE
  • 年發(fā)文量39

Nuclear Medicine And Molecular Imaging

期刊中文名:核醫(yī)學(xué)與分子成像ISSN:1869-3474E-ISSN:1869-3482

該雜志國際簡稱:NUCL MED MOLEC IMAG,是由出版商Springer Nature出版的一本致力于發(fā)布--研究新成果的的專業(yè)學(xué)術(shù)期刊。主要發(fā)表刊登有創(chuàng)見的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展,選載對學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學(xué)術(shù)影響力。

基本信息:
期刊簡稱:NUCL MED MOLEC IMAG
是否OA:未開放
是否預(yù)警:
Gold OA文章占比:5.93%
出版信息:
出版周期:6 issues per year
出版語言:English
出版商:Springer Nature
評價(jià)信息:
JCR分區(qū):Q3
影響因子:1.3
CiteScore:2.2
雜志介紹 JCR分區(qū) CiteScore 投稿經(jīng)驗(yàn)

雜志介紹

Nuclear Medicine And Molecular Imaging雜志介紹

《Nuclear Medicine And Molecular Imaging》是一本以English為主的未開放獲取國際優(yōu)秀期刊,中文名稱核醫(yī)學(xué)與分子成像,本刊主要出版、報(bào)道領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為1.3,最新CiteScore 指數(shù)為2.2。

本刊近期中國學(xué)者發(fā)表的論文主要有:

  • The Complementary Role of PET to Pathology in Differentiating the Primary Origin of a Malignant Skin Nodule from Liver or Lung

    Author: Ho, Ivan; Chen, Sirong; Yip, Yu; Ho, Chi Lai

  • Diagnosis of Seronegative Rheumatoid Arthritis by (68) Ga-FAPI PET/CT

    Author: Cheung, Shing Kee; Chen, Sirong; Wong, Yuet Hung; Wu, Kwan Kit; Ho, Chi Lai

英文介紹

Nuclear Medicine And Molecular Imaging雜志英文介紹

nuclear Medicine And Molecular Imaging (nucl Med Mol Imaging) Is An Official Journal Of The Korean Society Of Nuclear Medicine, Which Bimonthly Publishes Papers On February, April, June, August, October, And December About Nuclear Medicine And Related Sciences Such As Radiochemistry, Radiopharmacy, Dosimetry And Pharmacokinetics / Pharmacodynamics Of Radiopharmaceuticals, Nuclear And Molecular Imaging Analysis, Nuclear And Molecular Imaging Instrumentation, Radiation Biology And Radionuclide Therapy. The Journal Specially Welcomes Works Of Artificial Intelligence Applied To Nuclear Medicine. The Journal Will Also Welcome Original Works Relating To Molecular Imaging Research Such As The Development Of Molecular Imaging Probes, Reporter Imaging Assays, Imaging Cell Trafficking, Imaging Endo(exo)genous Gene Expression, And Imaging Signal Transduction. Nucl Med Mol Imaging Publishes The Following Types Of Papers: Original Articles, Reviews, Case Reports, Editorials, Interesting Images, And Letters To The Editor.

the Korean Society Of Nuclear Medicine (ksnm) ksnm Is A Scientific And Professional Organization Founded In 1961 And A Member Of The Korean Academy Of Medical Sciences Of The Korean Medical Association Which Was Established By The Medical Services Law. The Aims Of Ksnm Are The Promotion Of Nuclear Medicine And Cooperation Of Each Member. The Business Of Ksnm Includes Holding Academic Meetings And Symposia, The Publication Of Journals And Books, Planning And Research Of Promoting Science And Health, And Training And Qualification Of Nuclear Medicine Specialists.

JCR分區(qū)(2023-2024年最新版)

Nuclear Medicine And Molecular Imaging雜志 JCR分區(qū)信息

按JIF指標(biāo)學(xué)科分區(qū)
學(xué)科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
收錄子集:ESCI
分區(qū):Q3
排名:138 / 204
百分位:

32.6%

按JCI指標(biāo)學(xué)科分區(qū)
學(xué)科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
收錄子集:ESCI
分區(qū):Q3
排名:152 / 204
百分位:

25.74%

JCR分區(qū):JCR分區(qū)來自科睿唯安公司,JCR是一個(gè)獨(dú)特的多學(xué)科期刊評價(jià)工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計(jì)信息的期刊評價(jià)資源。每年發(fā)布的JCR分區(qū),設(shè)置了254個(gè)具體學(xué)科。JCR分區(qū)根據(jù)每個(gè)學(xué)科分類按照期刊當(dāng)年的影響因子高低將期刊平均分為4個(gè)區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個(gè)部分的。

CiteScore 評價(jià)數(shù)據(jù)(2024年最新版)

Nuclear Medicine And Molecular Imaging雜志CiteScore 評價(jià)數(shù)據(jù)

  • CiteScore 值:2.2
  • SJR:0.34
  • SNIP:0.423
學(xué)科類別 分區(qū) 排名 百分位
大類:Medicine 小類:Radiology, Nuclear Medicine and Imaging Q3 204 / 333

38%

歷年影響因子和期刊自引率

投稿經(jīng)驗(yàn)

Nuclear Medicine And Molecular Imaging雜志投稿經(jīng)驗(yàn)

該雜志是一本國際優(yōu)秀雜志,在國際上有較高的學(xué)術(shù)影響力,行業(yè)關(guān)注度很高,已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,該雜志在綜合專業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高,對稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高,作為一本國際優(yōu)秀雜志,一般投稿過審時(shí)間都較長,投稿過審時(shí)間平均 ,如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。

免責(zé)聲明

若用戶需要出版服務(wù),請聯(lián)系出版商。